A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2001
12/27/2001	WO2001098295A1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
12/27/2001	WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
12/27/2001	WO2001098282A1 Benzoxazepinones and their use as squalene synthase inhibitors
12/27/2001	WO2001098279A2 Bis-arylsulfones
12/27/2001	WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones
12/27/2001	WO2001098253A2 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinicreceptor antagonists
12/27/2001	WO2001097846A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
12/27/2001	WO2001097837A1 Solubilised protein vaccines
12/27/2001	WO2001097829A2 Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
12/27/2001	WO2001097818A1 Fortifying vitamin compositions
12/27/2001	WO2001097810A2 Use of therapeutic benzamide derivatives
12/27/2001	WO2001097808A1 Combinations of depeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabete mellitus
12/27/2001	WO2001097800A1 Method of stabilizing medicinal compositions containing pravastatin
12/27/2001	WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
12/27/2001	WO2001097751A2 New formulation comprising a betablocker and optionally a cholesterol-lowering agent
12/27/2001	WO2001085719A9 Ortho-substituted anthranilic acid amides and their use as medicaments
12/27/2001	WO2001070254A9 Use of human not1 and not1a orphan receptors
12/27/2001	WO2001064645A3 Derivatives of quinoline as alpha-2 antagonists
12/27/2001	WO2001062086A8 Nutritional intervention composition for enhancing and extending satiety
12/27/2001	WO2001051608A3 Hybrid cells obtainable from antigen presenting cells
12/27/2001	WO2001046256A3 Vesicle trafficking proteins
12/27/2001	WO2001037782A3 Method and composition for the treatment of scars
12/27/2001	WO2001023390A3 Azepinoindole derivatives, the production and use thereof
12/27/2001	WO2001021159A3 Pharmaceutical composition of nateglinide and another antidiabetcagent
12/27/2001	WO2000064485A3 Specifically targeted catalytic antagonists and uses thereof
12/27/2001	WO1999056780A8 Isomer enriched conjugated linoleic acid compositions
12/27/2001	US20010056191 Hydantoin-containing glucokinase activators
12/27/2001	US20010056179 Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
12/27/2001	US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12
12/27/2001	US20010056063 Method of treating or preventing type 1 diabetes by oral administration of insulin
12/27/2001	US20010055629 Extraction
12/27/2001	US20010055627 Compositions And Methods For Regulating Lipoproteins And Hypercholesterolemia With Limonoids, Flavonoids And Tocotrienols
12/27/2001	CA2414228A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
12/27/2001	CA2414065A1 Cgi-69 compositions and methods of use
12/27/2001	CA2414033A1 Control of metabolism with compositions of the human 2-oxoglutarate carrier
12/27/2001	CA2414010A1 Secreted redox proteins
12/27/2001	CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders
12/27/2001	CA2413454A1 A g-protein coupled receptor
12/27/2001	CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists
12/27/2001	CA2413429A1 Benzoxazepinones and their use as squalene synthase inhibitors
12/27/2001	CA2413324A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
12/27/2001	CA2413299A1 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
12/27/2001	CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
12/27/2001	CA2412484A1 G-protein coupled receptors
12/27/2001	CA2411756A1 Mutation associated with epilepsy
12/27/2001	CA2411100A1 New formulation comprising a betablocker and optionally a cholesterol-lowering agent
12/27/2001	CA2410447A1 Bis-arylsulfones
12/27/2001	CA2410224A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
12/27/2001	CA2409778A1 Secreted proteins
12/27/2001	CA2409776A1 G-protein coupled receptors
12/27/2001	CA2407788A1 Method for activating peroxisome proliferator activated receptor-.gamma.
12/26/2001	CN1328554A Eletriptan hydrobromide monohydrate
12/26/2001	CN1328538A 2,4-pentadienoic acid derivatives having selective activity for retinoid X(RXR) receptors
12/26/2001	CN1328470A Chemokine receptor peptide vaccines for treatment and prevention of diabetes
12/26/2001	CN1328454A Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
12/26/2001	CN1328452A Use of benzoylguanidines for treatment of non-insulin-dependent diabetes mellitus
12/26/2001	CN1328417A Compositions and methods for treatment of mitochondrial diseases
12/26/2001	CN1328092A Process for extracting tea pigment and its application in treating hyperlipomia
12/26/2001	CN1327852A Chinese medicine for treating coronary heart disease, reducing blood fat and improving sleep and its preparing process
12/26/2001	CN1327850A American ginseng extract (CNT-2000) without residual agricultural chemical and its usage
12/26/2001	CN1327840A Medical wine for lossing weight and building up body and its preparing process
12/26/2001	CN1327826A Hypoglycemic capsule
12/26/2001	CN1327804A Health-care hypoglycemic tea
12/26/2001	CN1327793A Pyrrolo-triazine and pyrimidine compounds
12/26/2001	CN1327771A Antilipemic red beverage and its preparing process
12/26/2001	CN1076727C Novel triazolones as apolipoprotein-B synthesis inhibitors
12/26/2001	CN1076624C Nasally administrable compositions
12/26/2001	CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate
12/25/2001	US6333402 For therapy and diagnosis
12/25/2001	US6333353 Nutrients, foods, drugs
12/25/2001	US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics
12/25/2001	US6333325 Method of treating cytokine mediated diseases or conditions
12/25/2001	US6333188 Lactic acid bacteria preparation having biopurification activity
12/25/2001	US6333055 Use of ammonium compounds and/or urea
12/20/2001	WO2001096586A1 Antisense modulation of c/ebp alpha expression
12/20/2001	WO2001096574A1 Novel enzyme gene and its expression product
12/20/2001	WO2001096567A1 Novel g protein-coupled receptor protein and dna thereof
12/20/2001	WO2001096565A2 Binding agents: chimeric ligand/receptor proteins
12/20/2001	WO2001096553A1 Novel g protein-coupled receptor protein and dna thereof
12/20/2001	WO2001096547A2 Human kinases
12/20/2001	WO2001096546A2 Protein phosphatases
12/20/2001	WO2001096397A2 Cd154 variants and uses thereof
12/20/2001	WO2001096360A1 Antisense modulation of c/ebp beta expression
12/20/2001	WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
12/20/2001	WO2001096337A1 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
12/20/2001	WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists
12/20/2001	WO2001096331A1 Lactam inhibitors of factor xa and method
12/20/2001	WO2001096330A2 Thrombin receptor antagonists
12/20/2001	WO2001096327A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS
12/20/2001	WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
12/20/2001	WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
12/20/2001	WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/20/2001	WO2001096302A1 Piperidines for use as orexin receptor antagonists
12/20/2001	WO2001096300A1 Growth hormone secretagogues
12/20/2001	WO2001096295A2 2-cyanopyrrolidine derivatives and their use as medicaments
12/20/2001	WO2001096293A1 Vitamin d derivatives
12/20/2001	WO2001096281A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
12/20/2001	WO2001095937A2 Phytoestrogenic isoflavone compositions
12/20/2001	WO2001095935A1 Immunostimulatory nucleic acids for inducing a th2 immune response
12/20/2001	WO2001095928A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion

1 ... 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 ... 1298